![]() |
市场调查报告书
商品编码
1372031
2030 年植入式医疗设备市场预测:按产品类型、最终用户和地区分類的全球分析Implantable Medical Devices Market Forecasts to 2030 - Global Analysis By Product, Type, End User and By Geography |
根据Stratistics MRC的数据,2023年全球植入医疗设备市场规模为1,248亿美元,预计2030年将达到2,592亿美元,预测期内年复合成长率为11.0%。
医疗植入物是插入皮下或体内的物体或组织。植入物的目的是用人造零件替换缺少的身体部位。植入物可以出于治疗、诊断或监测目的而永久插入,也可以在完成其功能后移除。植入物用于身体的许多部位,具有多种用途,包括药物传输系统、神经假体、整形外科、心律调节器、心血管支架和心臟去颤器。植入物透过外科手术或药物程序全部或部分插入人体。植入式医疗设备的医疗益处包括提高病人安全和生活品质。
据世界卫生组织称,2022年,美国将记录5,000万例癫痫病例、10亿例偏头痛病例和40万例脊髓损伤病例。
这种方法越来越受欢迎,可以在职场和社交场合增强自信和自尊。人们越来越常采用脸部植入物等美容产品来增强个人的美丽和外观。此外,脸部植入物主要用于强调或矫正脸部骨骼的不规则性。虽然人们认为形状优美的下巴可以凸显男性的吸引力,但女性更喜欢方形下巴,因此下巴矫正对男性和女性都很重要。因此,这些因素对市场扩张产生了有益的影响。
植入式医疗设备的高昂初期成本可能对病患和医疗保健系统构成阻碍力。植入式医疗设备通常涉及高昂的成本,不仅包括设备本身,还包括手术、术后护理、未来设备替换和再次手术的费用。然而,这些费用对许多人来说可能令人望而却步,特别是如果他们没有足够的健康保险或保险。因此,有些患者因为负担不起而跳过植牙治疗。植入式医疗设备的高成本是市场扩张的主要障碍。
由于糖尿病、心血管疾病和神经退化性疾病等慢性病的患病不断增加,植入式医疗设备的需求量很大。这些疾病可以藉助神经刺激设备、心臟植入物和胰岛素帮浦等设备进行管理和治疗。此外,植入式医疗设备可以提供长期且永续的解决方案来控制慢性疾病,改善患者的生活品质并减轻持续护理和频繁医院就诊的压力。这些要素正在增加市场需求。
设备相容性是植入式医疗设备市场的关键障碍,因为很难将植入式医疗设备与患者的个人解剖结构和医疗状况正确匹配。每个人都有独特的解剖学和生理学特征。然而,由于这种可变性,植入式医疗技术必须进行定制,以满足每个患者的独特要求和特征。当该小工具需要专用佩戴或需要个人化治疗时,这个问题变得更加明显。因此,这是市场需求的障碍。
COVID-19大流行减少了对植入式医疗设备的需求,并增加了医护人员、助手和接受植入手术的患者交叉感染的风险,导致所有发生该疾病的国家对植入式医疗器械的需求减少起源于大流行期间的常规植入手术被叫停,大大减缓了该行业的扩张。由于 COVID-19 的爆发,植入式医疗设备市场受到了影响。
由于患者对微创手术的需求不断增加以及全球道路事故和伤害数量不断增加,预计金属细分市场将占据最大份额。此外,在整形外科手术中越来越多地使用金属植入物来为骨折和关节提供强有力的支撑,也有助于这一市场主导地位。因此,随着世界上越来越多的人患有关节炎,这个市场预计将继续扩大。
预计整形外科植入物领域将在预测期内出现良好的成长。整形外科植入物在世界各地广泛用于支撑骨折或取代缺失的骨骼或关节。导致骨折和关节损伤的事故数量不断增加,推动了这个市场的扩张。此外,类风湿性关节炎的患病正在增加,导致肘关节关节重建的增加。因此,现在正在进行更多的整形外科手术,这可能会在未来年度整形外科植入物的发展。
在估计期间,北美占据了最大的市场占有率。现在许多慢性病在北美很常见,老年人的数量也在增加。此外,先进医疗基础设施的可用性、微创手术的使用增加以及消费者医疗保健支出的增加是预计推动该地区医疗植入物市场成长的主要要素。此外,过去,北美居民对各种医疗植入物的可用性的认识不断提高,极大地促进了市场的扩张。
由于研发行业的扩张、医疗改革的激增、医疗基础设施的改善、拥有最先进设施的医院数量的增加、医疗技术的发展,亚太地区将在领域。预计医疗设备在识别、监测和管理各种疾病方面发挥重要作用,导致对医疗设备的需求不断增长。该地区与许多着名的医疗设备製造商和研究中心相连。
According to Stratistics MRC, the Global Implantable Medical Devices Market is accounted for $124.8 billion in 2023 and is expected to reach $259.2 billion by 2030 growing at a CAGR of 11.0% during the forecast period. Medical implants are objects or tissues that are inserted beneath the skin or inside the body. The purpose of implants is to replace missing body parts with prostheses. The implants may be inserted permanently for therapeutic, diagnostic, or monitoring purposes, or they may be withdrawn after their function has been met. Implants are utilized in numerous sections of the body for a variety of purposes, including drug delivery systems, neural prosthetics, orthopedics, pacemakers, cardiovascular stents, and defibrillators. Implants are inserted into the human body either fully or partially through surgical or medicinal procedures. Health care benefits from implantable medical devices include increased patient safety and quality of life.
According to the WHO, in 2022, the US recorded 50 million epilepsy cases; 1 billion migraine cases; and 400,000 spinal cord injury cases.
This method is becoming increasingly common in the workplace and during social gatherings that boost one's self-confidence and self-esteem. In order to improve one's beauty and physical appearance, aesthetic products like facial implants are being adopted more frequently. Additionally, facial implants are primarily used to enhance or correct the skeletal concavities and convexities of the face. Both genders are placing more emphasis on jaw correction since a well-defined jaw line is thought to accentuate a man's attractiveness, while an angular jaw line is preferred by women. As a result, these elements are having a beneficial effect on market expansion.
The high initial cost of implantable medical devices can be a deterrent for both patients and healthcare systems. Implantable medical devices frequently carry a hefty price tag that includes not only the cost of the device itself but also costs for the surgery, aftercare, and prospective device replacements or revisions in the future. However, these costs can be very expensive for many people, especially if they don't have proper health insurance or coverage. As a result, some patients could skip implantable treatments because they are unable to pay for them. The high cost of implantable medical devices is a significant barrier to market expansion.
Implantable medical devices are in high demand due to the increased prevalence of chronic diseases like diabetes, cardiovascular disease, and neurodegenerative disorders. These disorders can be managed and treated with the aid of devices like neuro stimulators, cardiac implants, and insulin pumps. Furthermore, implantable medical devices offer patients a higher quality of life and lessen the stress of ongoing care or frequent hospital visits by delivering a long-lasting and sustainable solution for controlling chronic disorders. These factors expand market demand.
As it might be difficult to make sure that implantable devices are properly integrated with a patient's individual anatomy and medical conditions, device compatibility is a significant barrier in the market for implantable medical devices. Each person has a unique anatomy and physiology. However, due to this variation, implanted medical technology must be customized to meet the unique requirements and traits of each patient. This problem is more obvious when gadgets need to be fitted specifically for a patient or when individualized treatment is needed. Therefore, it is a barrier to market demand.
The COVID-19 pandemic significantly slowed the industry's expansion as demand for implantable medical devices fell and all routine implantable surgeries were suspended in countries with the disease during the pandemic because of the high risk of cross-infection for medical personnel, auxiliaries, and patients undergoing implant procedures. The market for implantable medical devices has suffered as a result of the COVID-19 epidemic.
The metallic segment is estimated to hold the largest share, due to both the expanding desire for minimally invasive surgeries among patients and the increasing number of traffic accidents and trauma cases around the world. Additionally, the rising use of metal implants in orthopaedic operations to offer sturdy support to broken bones or joints is responsible for this market's dominance. Therefore, this market is anticipated to continue expanding as more people throughout the world have arthritis.
The orthopaedic implants segment is anticipated to have lucrative growth during the forecast period. Orthopaedic implants are widely utilized around the world to support broken bones and replace missing bones or joints. The expansion of this market is being boosted by the increasing number of accidents that result in broken bones and damaged joints. Additionally, the prevalence of rheumatoid arthritis is increasing, leading to an increase in elbow joint replacement surgery. As a result, there are currently more orthopaedic procedures being performed, which could spur the development of orthopaedic implants in the years to come.
North America commanded the largest market share during the extrapolated period. Numerous chronic diseases are now more common in North America, and the number of elderly people is rising. Additionally, the availability of an advanced healthcare infrastructure, an increase in the use of minimally invasive procedures, and rising consumer healthcare spending are the key factors anticipated to propel the growth of the regional medical implant market. Furthermore, in the past, growing consumer awareness of the availability of different medical implants among North American residents has greatly aided market expansion.
Asia Pacific is expected to witness profitable growth over the projection period, due to the expansion of the R&D industry, surge in healthcare reforms, improvement in healthcare infrastructure, increase in the number of hospitals with cutting-edge equipment, and technological developments in the field of implants. The vital role that medical devices play in the identification, monitoring and management of several illnesses contributes to an expanding need for them. The region is linked to a number of prominent medical equipment manufacturers and research centers.
Some of the key players in the Implantable Medical Devices Market include: Zimmer Biomet, Stryker, Dentsply Sirona, Terumo Corporation, Medtronic, Johnson & Johnson, Smith & Nephew, Danaher Corporation, Institut Straumann AG, Boston Scientific Corporation, Abbott, Alcon Laboratories, POLYTECH Health & Aesthetics, MicroPort Scientific Corporation, Bausch & Lomb, Cochlear Limited, Advanced Bionics Corporation and Henry Schein, Inc.
In February 2022, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company's CardioMEMS HF System to support the care of more people living with heart failure.
In February 2022, Boston Scientific Corporation announced the completion of its purchase of Baylis Medical Company Inc., a provider of innovative transseptal access solutions as well as guide wires, sheaths, and dilators used in catheter-based left-heart surgeries.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.